Logo

RheoGene Licenses Technology to Xenogen Biosciences to Develop Transgenic Mice

Sep 16, 2005

NEW YORK, Sept. 16 (GenomeWeb News) - RheoGene has licensed its RheoSwitch System technology to Xenogen Biosciences to develop transgenic mice as animal research models.

 

"The objective of this research collaboration is to establish and validate RheoSwitch technology within the transgenic mouse setting through the creation of genetically modified animals," said Thomas Tillett, RheoGene's president and CEO.

 

The companies will also collaborate on several projects aimed at controlling delivery and regulating expression of RNAi in order to address the problems of timing and localizinf active RNAi products to various target sites in vivo.

Breaking News
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.